325 CAPITAL LLC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001873893
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q3 2024 · 11 positions · Total reported value $236.19M · Top-10 concentration 98.2% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 16.7% · 0 new · 2 cut · 0 exited
Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q1 2026 → Q2 2026): +35.2% · vs SPY +20.4% · Prev Value $274.49M — last quarter positions weighted by this quarter price moves · ranking
In its Q3 2024 13F filing, 325 CAPITAL LLC disclosed 11 equity positions with a combined reported value of $236.19M. The filing implies a focused portfolio: its ten largest positions account for 98.2% of reported value. HoldingsHub classifies the profile as Small / Focused / Consumer Tilt.
The largest disclosed positions as of Q3 2024 were ASTH ($39.45M), BLBD ($38.93M), ATRO ($33.91M). By sector, the heaviest allocations are Consumer Discretionary 39.5%, Industrials 20.3%. Versus the prior quarter, allocation shifted toward Information Technology (+9.1pp), Consumer Discretionary (+6.3pp) and away from Health Care (-1.1pp), Industrials (-2.9pp).
Versus the prior quarter, 325 CAPITAL LLC opened 0 new positions, trimmed 2 and fully exited 0, a turnover rate of 16.7% of positions. The portfolio's overlap with the prior quarter was 71% of names.
The largest new positions opened in Q3 2024 were MSAI ($20.25M).
Of the 3 positions fully exited versus the prior quarter, the largest were IDCC ($11.90M), COHU ($11.31M), ZETA ($10.96M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q3 2024)
- MSAI MultiSensor AI Holdings Inc · $20.25M
Insider Transactions (Form 4)
Latest 325 CAPITAL LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
| Transaction date | Activity | Security | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-09-30 | Award | MultiSensor AI Holdings, Inc. | 4,210 | — | SEC filing |
| 2026-06-30 | Award | MultiSensor AI Holdings, Inc. | 3,738 | — | SEC filing |
| 2026-05-22 | Award | AMERICAN PUBLIC EDUCATION INC | 2,135 | — | SEC filing |
| 2026-05-04 | Opt exercise | TRANSACT TECHNOLOGIES INC | 1,700 | — | SEC filing |
Fund Profile
325 Capital is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 12 US equity positions with a combined value of $419.50M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: NEW YORK, NY, United States
- SEC registration: 801-119639 (status: Approved), registered 2020-10-16
- Regulatory AUM (Form ADV): $337.84M as of 2026-03-23
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 1 private funds, of which 1 hedge funds
- Website: 325capital.com
Portfolio Structure
- 12 positions · $419.50M reported value (Q2 2026)
- Top 10 holdings = 97.8% of reported value
- Largest position: ASTH (ASTRANA HEALTH INC) at 17.9%
- Average position size: $34.96M
Sector Tilt
- Consumer Discretionary 51.8%
- Information Technology 17.7%
- Real Estate 15.2%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q2 2026: 5 added, 2 reduced
- 5 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
680.91K | $39.45M | 16.70% | Add | |
| 2 |
|
811.76K | $38.93M | 16.48% | Reduce | |
| 3 |
|
1.74M | $33.91M | 14.36% | Add | |
| 4 |
|
2.27M | $33.48M | 14.18% | Add | |
| 5 |
|
4.55M | $25.38M | 10.74% | Add | |
| 6 |
|
9.38M | $20.25M | 8.57% Form 4 · 1 → |
New | |
| 7 |
|
2.02M | $14.92M | 6.32% | Add | |
| 8 |
|
1.14M | $13.94M | 5.90% | Add | |
| 9 |
|
1.37M | $6.75M | 2.86% | Add | |
| 10 |
|
1.01M | $4.92M | 2.08% | Hold | |
| 11 |
|
42.18K | $4.25M | 1.80% | Reduce | |
FAQ
What did 325 CAPITAL LLC buy in 2024-Q3?
In its 2024-Q3 13F filing, 325 CAPITAL LLC reported 11 equity positions worth $236.19M in aggregate; its largest disclosed positions were ASTH ($39.45M), BLBD ($38.93M), ATRO ($33.91M).
How large is 325 CAPITAL LLC's portfolio?
325 CAPITAL LLC reported $236.19M of long equity holdings across 11 positions as of 2024-Q3. Top-10 holdings account for 98.2% of reported value.
What is 325 CAPITAL LLC's investment style?
HoldingsHub classifies the portfolio as Small / Focused / Consumer Tilt, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.